A sea buckthorn seed oil nano-emulsion in the management of digital screen-induced ocular conditions
European Journal of Pharmaceutics and Biopharmaceutics · 2026-08 · 225 · 115118
DOI: 10.1016/j.ejpb.2026.115118 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2026-08. Verfasst von Mengfan Cheng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, Liaoning, PR China. Hauptthemen laut MEDLINE: Dry Eye Syndromes, Hippophae, Ophthalmic Solutions, Plant Oils. Die Arbeit nennt 46 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Department of Education of Liaoning Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
The widespread usage of digital devices has been associated with a significant increase in the incidence of various screen-related ocular diseases, particularly dry eye disease (DED), blue light (BL)-induced retinal damage, and myopia progression. These conditions not only severely compromise visual function and quality of life but also pose a growing challenge to global public health systems. To move beyond the conventional approach of treating each disease separately, this work investigates a consolidated solution that leverages the multi-target properties of sea buckthorn seed oil (SBO) for synergistic treatment of multiple ocular conditions. A nano-lipid eye drop formulation loaded with sea buckthorn seed oil (SBO-NE) was developed to achieve synergistic therapeutic effects. The SBO-NE formulation exhibited excellent stability and ocular tolerability in rabbits. In vivo, SBO-NE exhibited multifaceted therapeutic potential in a DED model, including significant promotion of tear secretion, acceleration of corneal repair, and anti-inflammatory efficacy that exceeded that of Soothe® XP. Furthermore, superior protection against BL-induced retinal damage was demonstrated compared with oral lutein supplementation. In addition, SBO-NE treatment delayed myopia progression. Although less effective than atropine sulfate eye drops, SBO-NE elicited a significant delay without inducing the dry eye typically associated with atropine. In summary, these findings suggest that SBO-NE represents a promising multi-target therapeutic candidate with broad-spectrum efficacy across multiple ocular conditions associated with digital device exposure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, Liaoning, PR China.
- School of Chinese Materia Medica, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, Liaoning, PR China.
- Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, Liaoning, PR China. Electronic address: zhaojianhhky@outlook.com.
- School of Chinese Materia Medica, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, Liaoning, PR China. Electronic address: pharmyt@163.com.
- Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, Liaoning, PR China. Electronic address: pharmzy@163.com.
Förderung
- National Key Research and Development Program of China
- Department of Education of Liaoning Province
- National Natural Science Foundation of China
Zitieren
APA
Cheng, M., Bi, X., Zhao, S., Xiang, R., Cai, S., Zhao, M., Wu, T., Su, Y., Ji, M., Zhao, J., Yin, T., & Zhang, Y. (2026). A sea buckthorn seed oil nano-emulsion in the management of digital screen-induced ocular conditions. European Journal of Pharmaceutics and Biopharmaceutics, 225, 115118. https://doi.org/10.1016/j.ejpb.2026.115118
Vancouver
Cheng M, Bi X, Zhao S, Xiang R, Cai S, Zhao M, et al. A sea buckthorn seed oil nano-emulsion in the management of digital screen-induced ocular conditions. European Journal of Pharmaceutics and Biopharmaceutics. 2026;225:115118. doi:10.1016/j.ejpb.2026.115118
BibTeX
@article{Cheng2026,
author = {Cheng, Mengfan and Bi, Xiaoshuang and Zhao, Shan and Xiang, Ruolan and Cai, Shunqiao and Zhao, MeiTing and Wu, Tao and Su, Yu and Ji, Muse and Zhao, Jian and Yin, Tian and Zhang, Yu},
title = {A sea buckthorn seed oil nano-emulsion in the management of digital screen-induced ocular conditions},
journal = {European Journal of Pharmaceutics and Biopharmaceutics},
year = {2026},
volume = {225},
pages = {115118},
doi = {10.1016/j.ejpb.2026.115118}
}
EUVIMED